ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Multiconsult Asa

Multiconsult Asa (0R8N)

63.20
0.00
(0.00%)
Cerrado 05 Enero 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
63.20
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
63.20 Rango de 52 semanas 63.20
Capitalización de Mercado [m]
Precio Anterior
63.20
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
342
Acciones en circulación
27,675,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
5.50
Beneficio por acción (BPA)
11.49
turnover
5.63B
Beneficio neto
318.12M

Acerca de Multiconsult Asa

Sector
Services, Nec
Industria
Services, Nec
Sede
Oslo, Nor
Fundado
-
Multiconsult Asa is listed in the Services sector of the London Stock Exchange with ticker 0R8N. The last closing price for Multiconsult Asa was kr63.20. Over the last year, Multiconsult Asa shares have traded in a share price range of kr 63.20 to kr 63.20.

Multiconsult Asa currently has 27,675,000 shares in issue. The market capitalisation of Multiconsult Asa is kr1.75 billion. Multiconsult Asa has a price to earnings ratio (PE ratio) of 5.50.

0R8N Últimas noticias

Multiconsult - investing for growth

Multiconsult - investing for growth PR Newswire OSLO, Norway, Nov. 1, 2023 OSLO, Norway, Nov. 1, 2023 /PRNewswire/ -- Multiconsult ASA (OSE: MULTI) The robust organic revenue growth observed...

Multiconsult - investing for growth

Multiconsult - investing for growth PR Newswire OSLO, Norway, Nov. 1, 2023 OSLO, Norway, Nov. 1, 2023 /PRNewswire/ -- Multiconsult ASA (OSE: MULTI) The robust organic revenue growth observed...

Multiconsult - good quarter with strong organic growth and result

Multiconsult - good quarter with strong organic growth and result PR Newswire OSLO, Norway, Aug. 23, 2023 OSLO, Norway, Aug. 23, 2023  /PRNewswire/ -- Multiconsult ASA (OSE: MULTI) Multiconsult's...

Multiconsult - good quarter with strong organic growth and result

Multiconsult - good quarter with strong organic growth and result PR Newswire OSLO, Norway, Aug. 23, 2023 OSLO, Norway, Aug. 23, 2023  /PRNewswire/ -- Multiconsult ASA (OSE: MULTI) Multiconsult's...

Multiconsult first quarter 2023 - best quarter ever

Multiconsult first quarter 2023 - best quarter ever PR Newswire OSLO, Norway, May 10, 2023 OSLO, Norway, May 10, 2023 /PRNewswire/ -- Multiconsult ASA (OSE: MULTI) The positive trend and strong...

Multiconsult first quarter 2023 - best quarter ever

Multiconsult first quarter 2023 - best quarter ever PR Newswire OSLO, Norway, May 10, 2023 OSLO, Norway, May 10, 2023 /PRNewswire/ -- Multiconsult ASA (OSE: MULTI) The positive trend and strong...

Minutes from Annual General Meeting 2023

Minutes from Annual General Meeting 2023 PR Newswire OSLO, Norway, April 13, 2023 OSLO, Norway, April 13, 2023 /PRNewswire/ -- Multiconsult ASA (Oslo: MULTI) has held the 2023 annual general...

Minutes from Annual General Meeting 2023

Minutes from Annual General Meeting 2023 PR Newswire OSLO, Norway, April 13, 2023 OSLO, Norway, April 13, 2023 /PRNewswire/ -- Multiconsult ASA (Oslo: MULTI) has held the 2023 annual general...

Notice of annual general meeting in Multiconsult ASA

Notice of annual general meeting in Multiconsult ASA PR Newswire OSLO, Norway, March 16, 2023 OSLO, Norway, March 16, 2023 /PRNewswire/ -- Multiconsult (Oslo: MULTI) Annual general meeting of...

Notice of annual general meeting in Multiconsult ASA

Notice of annual general meeting in Multiconsult ASA PR Newswire OSLO, Norway, March 16, 2023 OSLO, Norway, March 16, 2023 /PRNewswire/ -- Multiconsult (Oslo: MULTI) Annual general meeting of...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10063.263.263.212663.2DE
40063.263.263.234863.2DE
120063.263.263.234263.2DE
260063.263.263.221563.2DE
520063.263.263.212963.2DE
1560063.263.263.219063.2DE
2600063.263.263.233563.2DE

0R8N - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Multiconsult Asa?
El precio actual de las acciones de Multiconsult Asa es kr 63.20
¿Cuántas acciones de Multiconsult Asa están en circulación?
Multiconsult Asa tiene 27,675,000 acciones en circulación
¿Cuál es la capitalización de mercado de Multiconsult Asa?
La capitalización de mercado de Multiconsult Asa es NOK 1.75B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Multiconsult Asa?
Multiconsult Asa ha negociado en un rango de kr 63.20 a kr 63.20 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Multiconsult Asa?
El ratio precio/beneficio de Multiconsult Asa es 5.5
¿Cuál es el ratio de efectivo a ventas de Multiconsult Asa?
El ratio de efectivo a ventas de Multiconsult Asa es 0.31
¿Cuál es la moneda de reporte de Multiconsult Asa?
Multiconsult Asa presenta sus resultados financieros en NOK
¿Cuál es el último ingresos anual de Multiconsult Asa?
El último ingresos anual de Multiconsult Asa es NOK 5.63B
¿Cuál es el último beneficio anual de Multiconsult Asa?
El último beneficio anual de Multiconsult Asa es NOK 318.12M
¿Cuál es la dirección registrada de Multiconsult Asa?
La dirección registrada de Multiconsult Asa es NEDRE SKOYEN VEI 2, POSTBOKS 265 SK��YEN, OSLO, 0213
¿Cuál es la dirección del sitio web de Multiconsult Asa?
La dirección del sitio web de Multiconsult Asa es www.multiconsult.no
¿En qué sector industrial opera Multiconsult Asa?
Multiconsult Asa opera en el sector SERVICES, NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M
nowwhat2 nowwhat2 6 minutos hace
editing
https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg
XRPUSD
boi568 boi568 13 minutos hace
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 25 minutos hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 27 minutos hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 29 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 30 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 30 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 32 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 33 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 35 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 35 minutos hace
Not good, thanks for sharing.
sand sand 42 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 42 minutos hace
Moving hard soon 
EFSH
mining101 mining101 44 minutos hace
Superb
MEGL
benz280c benz280c 51 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 57 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 58 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hora hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hora hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hora hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hora hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con

Su Consulta Reciente

Delayed Upgrade Clock